Access cutting-edge kaposi sarcoma treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access kaposi sarcoma specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kaposi sarcoma treatment provided free
This phase II trial studies how well ixazomib works in treating patients with Kaposi sarcoma. Ixazomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Sponsor: AIDS Malignancy Consortium
Check if you qualify for this kaposi sarcoma clinical trial in Chicago, IL
If you're searching for kaposi sarcoma treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kaposi sarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.